Contraceptive Recommendations for Women with Migraines

Risk Stratification by Migraine Type

Women with migraine with aura should avoid combined hormonal contraceptives containing estrogen due to increased stroke risk, and should instead use progestogen-only contraceptives, copper IUDs, or barrier methods 1, 2
Estrogen-containing contraceptives are contraindicated in women with migraine with aura due to substantially elevated ischemic stroke risk (OR 2.08 to 16.9 for ischemic stroke) 3
The American Heart Association/American Stroke Association explicitly recommends avoiding oral contraceptive agents with exogenous estrogen in women with migraine with aura, particularly when combined with smoking 1, 2
The combination of migraine with aura and estrogen-containing contraceptives creates unacceptable vascular risk, even without prior stroke history 1

The quality of evidence linking estrogen-containing contraceptives to stroke in migraine is acknowledged as low, but the potential severity of outcomes justifies cautious prescribing 1

For women with confirmed menstrual-related migraine, perimenstrual preventive treatment with long-acting NSAIDs or triptans for 5 days, beginning 2 days before expected menstruation, may be used if acute treatment fails 4

Progestin-only pills (POPs) work primarily by thickening cervical mucus rather than inhibiting ovulation, and require very strict adherence (same time daily) and are associated with irregular bleeding patterns, which should be discussed upfront to improve compliance, according to the American Academy of Pediatrics 5
The use of progestin-only pills (POPs) is recommended as the safest option for women with menstrual headaches without aura, as it avoids estrogen entirely, eliminating the stroke risk and estrogen-withdrawal headache mechanism, although the specific citation for this fact is not provided, the American College of Obstetricians and Gynecologists recommends POPs as a first-line option 5

For POPs, no specific monitoring is required beyond routine contraceptive follow-up, according to the American Academy of Pediatrics 5